A Running Handoff
Executive SummaryThe sale of what is effectively Hoechst Marion Roussel's US development organization--preclinical through Phase IV--to a major CRO is good news for HMR for the employees. Along with the facility, Quintiles is taking on all of HMR's 550 development employees and will probably add another 900 or so workers as it expands the business.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.